BANK OF MONTREAL /CAN/ - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,000
-83.3%
192
-82.6%
0.00%
Q4 2020$6,000
-33.3%
1,104
+231.5%
0.00%
Q3 2020$9,000
-50.0%
333
-41.8%
0.00%
Q2 2020$18,000
-51.4%
572
-29.7%
0.00%
Q4 2019$37,0008140.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders